Clinical trial
Efficacy and Safety of a Purified Standardised Wasp Venom Preparation
NCT00263926 · Allergopharma GmbH & Co. KG, Industry · Completed
Key facts
| NCT number | NCT00263926 |
|---|---|
| Title | Efficacy and Safety of a Purified Standardised Wasp Venom Preparation |
| Official title | Immunotherapy of Wasp Venom Allergy: Comparison of a Purified Preparation to Conventional Aqueous Wasp Venom in an Open Controlled Study |
| Lead sponsor | Allergopharma GmbH & Co. KG, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Allergy |
| Intervention type | Biological |
| Interventions | wasp venom |
| Start date | Mar 1, 2001 |
| Primary completion | May 1, 2007 |
| Completion | Nov 1, 2010 |
| First posted | Dec 12, 2005 |
| Last update posted | Mar 11, 2013 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: